Table 1.

Reported cases of plasmacytosis in Korean patients [7–10].

Case number	Author	Age/sex	Duration prior to diagnosis	Extracutaneous involvement	Comorbidities	Treatment/response
(1)	Lee et al. [7]	52/M	4 years	Lymphatics, spleen	None	Melphalan/improved
(2)	Lee et al. [8]	54/M	5 years	Lymphatics, bone marrow, kidney	CKD	Prednisolone, mycophenolate/moderate regression
(3)	Lee et al. [9]	48/F	3 years	Lymphatics, lungs	None	Prednisone, melphalan/mild improvement
(4)	Amin et al. [10]	49/M	4 years	Lymphatics	None	Cyclophosphamide, doxorubicin, vincristine, prednisone and then rituximab/minimal response

F, female; M, male; CKD, chronic kidney disease.